Draft Guidance On Certification Creates Ambiguity

Law360, New York (May 30, 2008, 12:00 AM EDT) -- The Public Health Service Act (PHSA) now requires that submission of certain applications pursuant to the drug, device or biologics provisions of the Federal Food, Drug, and Cosmetic Act (FFDCA) or the PHSA be accompanied by a certification attesting that all applicable clinical trial registration and posting requirements have been met. See Section 402(j)(5)(B) of the PHSA; 42 U.S.C. §282(j)(5)(B).

This certification requirement became law as part of the new clinical trial transparency regime enacted by §801 of the Food and Drug Administration Act Amendments of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.